Skip to main content
CORT logo

CORT

Corcept Therapeutics Incorporated.

$63.57

2.17%

Trade Ideas Performance

Latest Closed Trade Idea

$63.57

2.17%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

8

Social

46

About

Events of Corcept Therapeutics Incorporated. (CORT)

Corcept Therapeutics' stock surged 46.2% over the past six months, reaching an all-time high of $126.38 on August 24, 2026. The company reported strong Q3 2026 financial performance with revenue of $340.5 million, a 64% increase over Q3 2025, and adjusted earnings per share of $1.01, exceeding analyst expectations, driven by sales of Korlym and Lifyorli. Despite these strong results, the stock fell 3.9% in after-hours trading as the company reiterated its full-year 2026 revenue guidance of $1.1 billion to $1.2 billion, which disappointed some investors. In October 2026, a Consensus Report on the Management of Type 2 Diabetes recommended screening for hypercortisolism in diabetic patients with poor glucose control and cited mifepristone as a potentially beneficial treatment. Positive results from the Phase 2 BELLA Part A trial of Lifyorli combined with nab-paclitaxel and bevacizumab in platinum-resistant ovarian cancer were announced. Analyst price targets have been raised, with Piper Sandler increasing its target to $173.00/share, and the consensus price target is around $139.50. As of October 30, 2026, one analyst downgraded Corcept Therapeutics' stock over the last month. The stock's 52-week range has been between $28.66 and $126.38, and as of October 14, 2026, the share price was $116.24, marking a 51.33% increase over the past year.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)